Clinical Trial Update: Preoperative Bexarotene Treatment for Cushing's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial from University of Virginia evaluating preoperative bexarotene for Cushing's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease

Drugs mentioned

• Bexarotene (Targretin) (bexarotene)

Snippet

Sponsor: University of Virginia | Conditions: Cushing's Disease | Phase 1, Phase 2 | Status: UNKNOWN